Evaluation of effectiveness and safety of hemofilter "Excelflo"(AEF) by continuous hemofiltration treatment for patients who suffer from acute renal failure.

Evaluation of effectiveness and safety of hemofilter "Excelflo"(AEF) by continuous hemofiltration treatment for patients who suffer from acute renal failure. - Evaluation of effectiveness of hemofilter "EXCELFLO"

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003390

Enrollment

Registered

2010-07-01

Start date

2010-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SIRS patients who suffer from acute renal failure

Interventions

EXCELFLO - PANFLO PANFLO - EXCELFLO

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are 16 years of age and older who suffer from acute renal failure and SIRS.

Exclusion criteria

Exclusion criteria: 1.Patients who are pregnant or maybe pregnant. 2.Children under 15 years of age. 3.Patients who may possibly be at high risk after consulting with a doctor.

Design outcomes

Primary

Measure	Time frame
Amount of adsorbed LDH and fiburin on the membrane after treatment	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

Evaluation of effectiveness and safety of hemofilter &quot;Excelflo&quot;(AEF) by continuous hemofiltration treatment for patients who suffer from acute renal failure.